Primary Angle-Closure Glaucoma
8
3
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
Predicting the Risk of Partial Ciliary Block After Cataract and Goniosynechialysis Surgery in Primary Angle-Closure Disease
The Multi-Omics Analysis of Lens Zonule Relaxation in The PACG Pathogenesis
Vitreous Zonule in Primary Angle-Closure Glaucoma
Kahook Dual Blade Goniotomy in Chronic Primary Angle-Closure Glaucoma
Effect of Infusion Warming on Mannitol Infusion Pain in Patients With Acute Ocular Hypertension
Liwan Eye Study: the Fourth Follow-up
Prevalence of Ocular Surface Disease in Malaysian Glaucoma Patients
Phacoemulsification Versus Phacoemulsification With Micro-bypass Stent